| SC 13G | 2024-02-16 | MILLENNIUM MANAGEMENT LLC | KALA BIO, Inc. | 135,096 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-14 | BAKER BROS. ADVISORS LP | KALA BIO, Inc. | 269,213 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Checkpoint Capital L.P. | KALA BIO, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-01-29 | INTEGRATED CORE STRATEGIES (US) LLC | KALA BIO, Inc. | 130,704 | 4.9% | EDGAR |
| SC 13D/A | 2023-10-18 | Longitude Capital Partners II, LLC | KALA BIO, Inc. | 57,541 | 2.3% | EDGAR |
| SC 13G | 2023-06-15 | Checkpoint Capital L.P. | Kala Pharmaceuticals, Inc. | 228,032 | 9.7% | EDGAR |
| SC 13D/A | 2023-02-14 | Longitude Capital Partners II, LLC | Kala Pharmaceuticals, Inc. | 57,541 | 3.4% | EDGAR |
| SC 13G | 2023-02-14 | BAKER BROS. ADVISORS LP | Kala Pharmaceuticals, Inc. | 180,913 | 10.0% | EDGAR |
| SC 13G | 2023-01-17 | INTEGRATED CORE STRATEGIES (US) LLC | Kala Pharmaceuticals, Inc. | 107,200 | 6.7% | EDGAR |
| SC 13D/A | 2022-06-03 | RA CAPITAL MANAGEMENT, L.P. | Kala Pharmaceuticals, Inc. | 3,412,868 | 4.7% | EDGAR |
| SC 13D/A | 2022-06-01 | RA CAPITAL MANAGEMENT, L.P. | Kala Pharmaceuticals, Inc. | 6,194,789 | 8.5% | EDGAR |
| SC 13D/A | 2022-05-25 | RA CAPITAL MANAGEMENT, L.P. | Kala Pharmaceuticals, Inc. | 8,045,299 | 11.1% | EDGAR |
| SC 13D/A | 2022-04-01 | RA CAPITAL MANAGEMENT, L.P. | Kala Pharmaceuticals, Inc. | 10,914,613 | 15.0% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Kala Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-01-10 | BlackRock Inc. | Kala Pharmaceuticals, Inc. | 3,134,773 | 4.8% | EDGAR |
| SC 13D | 2021-11-26 | Lagunita Biosciences, LLC | Kala Pharmaceuticals, Inc. | 5,144,390 | 7.0% | EDGAR |
| SC 13D | 2021-11-26 | Lagunita, LLC | Kala Pharmaceuticals, Inc. | 5,144,390 | 7.0% | EDGAR |
| SC 13D | 2021-11-24 | Blumenkranz Mark S. | Kala Pharmaceuticals, Inc. | 5,144,390 | 7.0% | EDGAR |
| SC 13D/A | 2021-10-28 | RA CAPITAL MANAGEMENT, L.P. | Kala Pharmaceuticals, Inc. | 10,961,533 | 16.8% | EDGAR |
| SC 13G/A | 2021-10-14 | ORBIMED ADVISORS LLC | Kala Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |